Literature DB >> 27693518

On the kinetics of chitosan/tripolyphosphate micro- and nanogel aggregation and their effects on particle polydispersity.

Yan Huang1, Yakov Lapitsky2.   

Abstract

Submicron chitosan/tripolyphosphate (TPP) particles are widely investigated as nanocarriers for drugs, genes and vaccines. One of the key particle properties that requires control is their size distribution, which depends on the extent of chitosan/TPP primary nanoparticle aggregation into higher-order submicron colloids. To provide a better understanding of this higher-order aggregation process, this study analyzes the factors that control chitosan/TPP particle aggregation kinetics in the presence of free TPP (such as present during particle formation). The aggregation rates exhibit a sharp power-law decrease with the monovalent salt concentration and a power-law increase with the free TPP concentration. Moreover, the aggregation rates increase with the pH and with the chitosan degree of deacetylation (DD). These variations in aggregation rates reflect the effects of monovalent salt, TPP concentration, pH and chitosan DD on particle bridging by the surface-bound TPP. Furthermore, these aggregation rates are much faster than those predicted based on Derjaguin and Landau, Verwey and Overbeek (DLVO) interaction potentials, which might reflect nonuniformities in particle shape and charge, and/or complications caused by particle softness. Finally, implications of the above aggregation kinetics on the uniformity of chitosan/TPP micro- and nanogel size are analyzed, where we: (1) show how particle polydispersity can be diminished by lowering the chitosan DD; and (2) explain the opposing results on how chitosan/TPP particle polydispersity is affected by monovalent salt.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aggregation; Chitosan; Ionic crosslinking; Microgels; Nanoparticles; Polydispersity; Tripolyphosphate

Mesh:

Substances:

Year:  2016        PMID: 27693518     DOI: 10.1016/j.jcis.2016.09.050

Source DB:  PubMed          Journal:  J Colloid Interface Sci        ISSN: 0021-9797            Impact factor:   8.128


  7 in total

1.  Design and Evaluation of pH Sensitive PEG-Protamine Nanocomplex of Doxorubicin for Treatment of Breast Cancer.

Authors:  Ikhlaque Ahmad; Muhammad Farhan Ali Khan; Abbas Rahdar; Saddam Hussain; Fahad Khan Tareen; Muhammad Waqas Salim; Narges Ajalli; Muhammad Imran Amirzada; Ahmad Khan
Journal:  Polymers (Basel)       Date:  2022-06-14       Impact factor: 4.967

2.  Zinc-Modified Nanotransporter of Doxorubicin for Targeted Prostate Cancer Delivery.

Authors:  Sylvie Skalickova; Martin Loffelmann; Michael Gargulak; Marta Kepinska; Michaela Docekalova; Dagmar Uhlirova; Martina Stankova; Carlos Fernandez; Halina Milnerowicz; Branislav Ruttkay-Nedecky; Rene Kizek
Journal:  Nanomaterials (Basel)       Date:  2017-12-08       Impact factor: 5.076

3.  Modulation of Chitosan-TPP Nanoparticle Properties for Plasmid DNA Vaccines Delivery.

Authors:  Renato Nunes; Ana Sofia Serra; Aiva Simaite; Ângela Sousa
Journal:  Polymers (Basel)       Date:  2022-04-01       Impact factor: 4.329

Review 4.  Nanoparticles as a Solution for Eliminating the Risk of Mycotoxins.

Authors:  Pavel Horky; Sylvie Skalickova; Daria Baholet; Jiri Skladanka
Journal:  Nanomaterials (Basel)       Date:  2018-09-14       Impact factor: 5.076

Review 5.  Research progress of self-assembled nanogel and hybrid hydrogel systems based on pullulan derivatives.

Authors:  Tao Zhang; Ruyi Yang; Shengnan Yang; Jibin Guan; Dong Zhang; Yan Ma; Hongzhuo Liu
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

Review 6.  Self-Assembled Nanogels Based on Ionic Gelation of Natural Polysaccharides for Drug Delivery.

Authors:  Huimin Wang; Hong Deng; Menghan Gao; Weiqi Zhang
Journal:  Front Bioeng Biotechnol       Date:  2021-07-16

7.  Design and Development of Levodopa Loaded Polymeric Nanoparticles for Intranasal Delivery.

Authors:  Mohd Zulhelmy Ahmad; Akmal Hidyat Bin Sabri; Qonita Kurnia Anjani; Juan Domínguez-Robles; Normala Abdul Latip; Khuriah Abdul Hamid
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.